Literature DB >> 25938037

A comparative study on the transplantation of different concentrations of human umbilical mesenchymal cells into diabetic rats.

Jia-Hui Kong1, Dan Zheng1, Song Chen1, Hong-Tao Duan1, Yue-Xin Wang1, Meng Dong1, Jian Song1.   

Abstract

AIM: To observe the effects of intravitreal injections of different concentrations of human umbilical mesenchymal stem cells on retinopathy in rats with diabetes mellitus.
METHODS: Healthy and adult male Sprague-Dawley (SD) rats were randomly assigned to a normal control group (group A), a diabetic retinopathy (DR) blank control group (group B), a high-concentration transplantation group (group C), a low-concentration transplantation group (group D) and a placebo transplantation group (group E). The expression of nerve growth factor (NGF) protein in the retinal layers was detected by immunohistochemical staining at 2, 4, 6 and 8wk.
RESULTS: The expression of NGF was positive in group A and most positive in the retinal ganglion cell layer. In groups B and E, the expression of NGF was positive 2wk after transplantation and showed an increase in all layers. However, the level of expression had decreased in all layers at 4wk and was significantly reduced at 8wk. In groups C and D, the expression of NGF had increased at 2wk and continued to increase up to 8wk. The level of expression in group C was much higher than that in group D.
CONCLUSION: DR can be improved by intravitreal injection of human umbilical mesenchymal stem cells. High concentrations of human umbilical mesenchymal stem cells confer a better protective effect on DR than low concentrations.

Entities:  

Keywords:  diabetic retinopathy; human umbilical mesenchymal stem cells; nerve growth factor; stem cell therapy

Year:  2015        PMID: 25938037      PMCID: PMC4413587          DOI: 10.3980/j.issn.2222-3959.2015.02.08

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

Review 1.  Mesenchymal stem cells and potential applications in treating ocular disease.

Authors:  Aaron W Joe; Kevin Gregory-Evans
Journal:  Curr Eye Res       Date:  2010-11       Impact factor: 2.424

Review 2.  Clinical applications of NGF in ocular diseases.

Authors:  Alessandro Lambiase; Flavio Mantelli; Marta Sacchetti; Simona Rossi; Luigi Aloe; Stefano Bonini
Journal:  Arch Ital Biol       Date:  2011-06       Impact factor: 1.000

Review 3.  Methods of isolation, expansion, differentiating induction and preservation of human umbilical cord mesenchymal stem cells.

Authors:  Dong-Rui Li; Jian-Hui Cai
Journal:  Chin Med J (Engl)       Date:  2012-12       Impact factor: 2.628

Review 4.  Diabetic retinopathy: neuron protection as a therapeutic target.

Authors:  Xinyuan Zhang; Ningli Wang; Gaetano R Barile; Shisan Bao; Mark Gillies
Journal:  Int J Biochem Cell Biol       Date:  2013-03-15       Impact factor: 5.085

Review 5.  Treatment viability of stem cells in ophthalmology.

Authors:  V Swetha E Jeganathan; Muthusamy Palanisamy
Journal:  Curr Opin Ophthalmol       Date:  2010-05       Impact factor: 3.761

6.  Differentiation of human bone marrow-derived mesenchymal stem cells into neural-like cells by co-culture with retinal pigmented epithelial cells.

Authors:  Ling-Ling Yang; Qing-Jun Zhou; Yao Wang; Yi-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

7.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Authors:  Quan Dong Nguyen; David M Brown; Dennis M Marcus; David S Boyer; Sunil Patel; Leonard Feiner; Andrea Gibson; Judy Sy; Amy Chen Rundle; J Jill Hopkins; Roman G Rubio; Jason S Ehrlich
Journal:  Ophthalmology       Date:  2012-02-11       Impact factor: 12.079

8.  Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema.

Authors:  Paulo I Rauen; Jefferson A S Ribeiro; Felipe P P Almeida; Ingrid U Scott; André Messias; Rodrigo Jorge
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

Review 9.  Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.

Authors:  Will Whitmire; Mohammed Mh Al-Gayyar; Mohammed Abdelsaid; Bilal K Yousufzai; Azza B El-Remessy
Journal:  Mol Vis       Date:  2011-01-28       Impact factor: 2.367

Review 10.  Nerve growth factor: from the early discoveries to the potential clinical use.

Authors:  Luigi Aloe; Maria Luisa Rocco; Patrizia Bianchi; Luigi Manni
Journal:  J Transl Med       Date:  2012-11-29       Impact factor: 5.531

View more
  5 in total

Review 1.  Pathogenic roles of microvesicles in diabetic retinopathy.

Authors:  Wei Zhang; Song Chen; Ming-Lin Liu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

2.  Protective effects of umbilical cord mesenchymal stem cell exosomes in a diabetic rat model through live retinal imaging.

Authors:  Yan Fu; Xiang Gao; Guang-Hui He; Song Chen; Zhao-Hui Gu; Yue-Ling Zhang; Li-Ying Li
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

3.  Retinal Electrophysiological Effects of Intravitreal Bone Marrow Derived Mesenchymal Stem Cells in Streptozotocin Induced Diabetic Rats.

Authors:  Eren Çerman; Tolga Akkoç; Muhsin Eraslan; Özlem Şahin; Selvinaz Özkara; Fugen Vardar Aker; Cansu Subaşı; Erdal Karaöz; Tunç Akkoç
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

4.  Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy.

Authors:  Wei Zhang; Yuexin Wang; Jiahui Kong; Meng Dong; Hongtao Duan; Song Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 5.  Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.

Authors:  Vladimir Holan; Katerina Palacka; Barbora Hermankova
Journal:  Cells       Date:  2021-03-07       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.